Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease (Proceeding of the National Academy of Sciences of the United States of America (2009) 106, 1, (18-23) doi: 10.1073/pnas.0806787106);Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 1, 2009, Pages 18-23

  Van Kasteren, Sander I ^a   Campbell, Sandra J ^a   Serres, Sébastien ^a   Anthony, Daniel C ^a   Sibson, Nicola R ^a   Davis, Benjamin G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Carbohydrates; MRI; Multiple sclerosis; Selectins

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCAN; GLYCONANOPARTICLES; LIGAND; NANOPARTICLE; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BRAIN DISEASE; COMPLEX FORMATION; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE MARKER; ENDOTHELIUM; IMAGING AND DISPLAY; IN VIVO STUDY; INFLAMMATION; MALE; MAMMAL; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL DETECTION; SPECTROMETER; SYMPTOMATOLOGY;

MAMMALIA;

EID: 58549108776     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0900259106     Document Type: Erratum

References (56)

1. Tsourkas A, et al. (2005) In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjugate Chem 16:576-581.
2. McAteer MA, et al. (2007) In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med 13:1253-1258.
3. Cayrol R, et al. (2008) Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol 9:137-145.
4. Lee BPL, Imhof BA (2008) Lymphocyte transmigration in the brain: A new way of thinking. Nat Immunol 9:117-118.
5. Sibson NR, et al. (2004) MRI detection of early endothelial activation in brain inflammation. Magn Reson Med 51:248-252.
6. Barber PA, et al. (2004) MR molecular imaging of early endothelial activation in focal ischemia. Ann Neurol 56:116-120.
7. Boutry S, et al. (2005) Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magn Reson Med 53:800-807.
8. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L (2005) Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 23:1418-1423.
9. Gasser DL, Newlin CM, Palm J, Gonatas NK (1973) Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 181:872-873.
10. Williams RM, Moore MJ (1973) Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J Exp Med 138:775-783.
11. Martin R, McFarland HF McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187.
12. Sharkey J, Ritchie IM, Kelly PAT (1993) Perivascular microapplication of endothelin-1: A new model for focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 13:865-871.
13. Sharkey J, Butcher SP (1995) Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery. J Neurosci Methods 60:125-131.
14. Sibson NR, et al. (2008) Acute astrocyte activation in brain detected by MRI: New insights into T1 hypointensity. J Cereb Blood Flow Metab 28:621-632.
15. Von Andrian, U. H. Mackay, C. R. T-cell function and migration: Two sides of the same coin (2000) N Engl J Med 343:1020-1034.
16. Halkes KM, Carvalho De Souza A, Maljaars CEP, Gerwig GJ, Kamerling JP (2005) A facile method for the preparation of gold glyconanoparticles from free oligosaccharides and their applicability in carbohydrate-protein interaction studies Eur J Org Chem 3650-3659.
17. Carvalho De Souza A, et al. (2005) Gold glyconanoparticles as probes to explore the carbohydrate-mediated self-recognition of marine sponge cells. ChemBioChem6:828-831.
18. Carvalho De Souza A, et al. (2004) Synthesis of gold glyconanoparticles: Possible probes for the exploration of carbohydrate-mediated self-recognition of marine sponge cells. Eur J Org Chem 4323-4339.
19. De la Fuente JM, et al. (2001) Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions. Angew Chem Intl Ed 40:2258-2261.
20. De La Fuente JM, Penades S (2005) Glyco-quantum dots: A new luminescent system with multivalent carbohydrate display. Tetrahedron Asymmetry 16:387-391.
21. De La Fuente JM, Penades S (2004) Understanding carbohydrate-carbohydrate interactions by means of glyconanotechnology. Glycoconjugate J 21:149-163.
22. Derfus AM, Chan WCW, Bhatia SN (2004) Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4:11-18.
23. Schlenoff JB, Li M, Ly H (1995) Stability and self-exchange in alkanethiol monolayers. J Am Chem Soc 117:12528-12536.
24. Zhao Y, Perez-Segarra W, Shi Q, Wei A (2005) Dithiocarbamate assembly on gold. J Am Chem Soc 127:7328-7329.
25. Flynn NT, Tran TNT, Cima MJ, Langer R (2003) Long-term stability of self-assembled monolayers in biological media. Langmuir 19:10909-10915.
26. Tanaka H, Ando Y, Wada M, Takahashi T (2005) Synthesis of DTPA-conjugated (1,4)-linked 2-aminoglycosides varying in the anomeric configuration and their MRI contrast effect. Org Biomol Chem 3:3311-3328.
27. Andre JP, et al. (2004) Lanthanide(III) complexes of DOTA-glycoconjugates: A potential new class of lectin-mediated medical imaging agents. Chem Eur J 10:5804-5816.
28. Fulton DA, et al. (2006) Glycoconjugates of gadolinium complexes for MRI applications. Chem Commun. 1064-1066.
29. Takahashi M, et al. (2000) Utilization of dendritic framework as a multivalent ligand: A functionalized gadolinium(III) carrier with glycoside cluster periphery. Tetrahedron Lett 41:8485-8488.
30. Baia P, et al. (2005) Lanthanide(III) chelates of DTPA bis(amide) glycoconjugates: Potential imaging agents targeted at the asyaloglycoprotein receptor. Eur J Inorg Chem 2110-2119.
31. Lundquist JJ, Toone EJ (2002) The cluster glycoside effect. Chem Rev 102:555-578.
32. Lee YC (1992) Biochemistry of carbohydrate-protein interaction. FASEB J 6:3193-3200.
33. Lee YC, Lee RT (1995) Carbohydrate-protein interactions: Basis of glycobiology. Acc Chem Res 28:321-326.
34. Mammen M, Choi SK, Whitesides GM (1998) Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Intl Ed 37:2754-2794.
35. Laconte L, Nitin N, Bao G (2005) Magnetic nanoparticle probes. Materials Today 8:32-38.
36. Bulte JWM, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499.
37. Josephson L, Tung CH, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-tat peptide conjugates. Bioconjugate Chem 10:186-191.
38. Bulte JWM, et al. (1999) Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci 96:15256-15261.
39. Perez JM, O'Loughin T, Simeone FJ, Weissleder R, Josephson L (2002) DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. J Am Chem Soc 124:2856-2857.
40. Palmacci S, Josephson L, Groman EV (1995). US 76829505669 (Advanced Magnetics).
41. Chan WC, White PD (2000) Fmoc Solid Phase Peptide Synthesis (Oxford Univ Press, Oxford).
42. Lee YC, Stowell CP, Krantz MJ (1976) 2-Imino-2-methoxyethyl 1-thioglycosides: New reagents for attaching sugars to proteins. Biochemistry 15:3956-3963.
43. Pearce OMT, et al. (2005) Glycoviruses: Chemical glycosylation retargets adenoviral gene transfer. Angew Chem Intl Ed 44:1057-1061.
44. Robinson MA, et al. (2004) LEAPT: Lectin-directed enzyme-activated prodrug therapy. Proc Natl Acad Sci USA 101:14527-14532.
45. Stowell CP, Lee YC (1982) Preparation of neoglycoproteins using 2-imino-2-methoxyethyl 1-thioglycosides. Methods Enzymol 83:278-288.
46. Sobenin IA, Tertov VV, Orekhov AN (1998) Optimization of the assay for sialic acid determination in low density lipoprotein. J Lipid Res 39:2293-2299.
47. Udenfrlend S, et al. (1972) Fluorescamine: A reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178:871-872.
48. Dwek RA, Edge CJ (1993) Analysis of glycoprotein-associated oligosaccharides. Annu Rev Biochem 62:65-100.
49. Nelson RM, Dolich S, Aruffo A, Cecconi O, Bevilacqua MP (1993) Higher-affinity oligosaccharide ligands for E-selectin. J Clin Investigation 91:1157.
50. Bernardes-Silva M, Anthony DC, Issekutz AC, Perry VH (2001) Recruitment of neutrophils across the blood-brain barrier: The role of E- and P-selectins. J Cereb Blood Flow Metab 21:1115-1124.
51. Anthony DC, Bolton SJ, Fearn S, Perry VH (1997) Age-related effects of interleukin-1β on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 120:435-444.
52. Blamire AM, et al. (2000) Interleukin-1b-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: A magnetic resonance study. J Neurosci 20:8153-8159.
53. Sibson NR, et al. (2007) Acute astrocyte activation in brain detected by MRI: New insights into T1 hypointensity J Cereb Blood Flow Metab.
54. Boutry S, Laurent S, Elst LV, Muller RN (2006) Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Med Mol Imaging 1:15-22.
55. Reynolds PR, et al. (2006) Detection of Vascular Expression of E-selectin in Vivo with MR-Imaging. Radiology 241:469-476.
56. Sibson NR, et al. (2002) TNF-{alpha} reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain 125:2446-2459.